1910 Genetics utilizes a multimodal AI platform that integrates computational data, wet lab proxy biological data, and wet lab ground truth biological data to enhance drug discovery for small and large molecules. The company focuses on delivering novel drug candidates for neurological, autoimmune diseases, and cancer while providing software solutions to pharmaceutical and technology partners.

Agility Robotics manufactures humanoid robots, specifically Digit, which integrates into material handling workflows to enhance operational efficiency in various industries. By automating labor-intensive tasks, Digit provides businesses with a cost-effective solution to workforce shortages and productivity challenges.

Amber Bio develops novel gene editing modalities capable of performing multi-kilobase edits to address previously undruggable patient populations. The company is creating a first-of-its-kind RNA writing platform designed to treat thousands of diverse mutations with a single therapeutic product. This approach moves beyond developing separate therapies for individual mutations in genetic medicine.

Anjuna provides a platform that utilizes confidential computing technologies to create secure enclaves for applications, ensuring data confidentiality without requiring changes to existing software. This technology enables organizations to process sensitive information in the cloud while maintaining strict privacy controls and protecting intellectual property.

Atomic AI develops next-generation RNA-centric medicines using machine learning and structural biology. Their ATOM-1 foundation model provides highly precise predictions of three-dimensional RNA structure, enabling access to previously unreachable therapeutic targets. The proprietary R&D platform integrates deep learning models with purpose-built wet-lab assays to accelerate drug discovery.

Ayar Labs has developed the first in-package optical I/O solution, utilizing the TeraPHY™ optical I/O chiplet and SuperNova™ remote light source to enable high-speed data transfer between chips. This technology addresses the limitations of traditional interconnects by providing 5-10 times higher bandwidth, 4-8 times greater power efficiency, and 10 times lower latency, essential for scaling AI infrastructure.

Provides a noninvasive cardiac scale that measures hemodynamic biomarkers, including fluid status and heart function, through sensors embedded in a standard-scale design. This at-home device delivers real-time data to clinical care teams, enabling timely interventions to prevent hospitalizations and improve management of chronic heart conditions.

Boxbot utilizes automated induction and ejection systems along with artificial intelligence to optimize parcel storage and sorting, achieving a storage density twice that of conventional systems. The technology addresses inefficiencies in package sorting for delivery vehicles, resulting in a 500% improvement in operational efficiency and reducing vehicle load times to under 15 minutes.

Branch provides a linking infrastructure that enables companies to create, manage, and measure deep links across mobile apps and websites, enhancing user engagement and conversion rates. By streamlining attribution and optimizing marketing spend, Branch helps over 100,000 brands improve their mobile growth and customer experience.

Databricks provides a unified Data Intelligence Platform that combines data lake and warehouse capabilities into a single, scalable environment for data storage, governance, ETL, analytics, and AI model development. The platform offers serverless PostgreSQL lakebases, integrated open‑source tools like Spark, Delta Lake, and MLflow, and multi‑cloud support to reduce operational complexity and total cost of ownership for enterprise data and AI teams.

De-Ice provides a chemical-free technology solution for aircraft de-icing prior to takeoff. This system eliminates the delays and operational costs associated with traditional glycol spraying methods. The result is improved airline on-time performance and a reduction in CO2 emissions.

D-Matrix has developed Corsair, an AI inference platform that achieves 60,000 tokens per second with 1 ms latency for Llama3 8B models, significantly enhancing throughput and energy efficiency in datacenters. This technology addresses the high computational costs and energy consumption associated with large-scale AI inference, enabling organizations to scale their AI capabilities sustainably.

Element Zero has developed a process to convert metal ores, including iron and nickel, into pure metals with zero carbon emissions. This technology addresses the environmental impact of traditional metal extraction methods by eliminating carbon output during production.

Fabric offers modular, automated fulfillment systems that can be installed in any footprint—from large centralized warehouses to compact micro‑fulfillment pods and containerized nano‑express units—supporting three temperature zones and a wide range of SKUs. Its proprietary robotics and end‑to‑end software handle inventory management, order picking, consolidation, and dispatch with real‑time visibility, reducing labor costs and space requirements while maintaining speed and accuracy for grocery, health‑and‑beauty, and on‑demand retailers.

Perlumi uses synthetic biology to develop solutions for increasing crop yields. Their technology aims to improve food, fiber, and materials production through biological engineering, leading to more sustainable and bountiful harvests.

Ideon Technologies utilizes cosmic-ray muon tomography through its REVEAL™ platform to accurately identify and map subsurface mineral deposits, addressing the challenge of geologic uncertainty in mining. This technology enables mining companies to make informed decisions by providing high-resolution imaging and comprehensive subsurface intelligence, significantly reducing exploration costs and risks.

Infinimmune uses its Complete Human sequencing technology® to capture fully paired heavy‑light antibody sequences from up to 300 million B cells, building the world’s largest database of natural human antibodies. Its Anthrobody® library‑on‑B‑cell platform and GLIMPSE™ AI‑driven language model enable rapid selection, affinity maturation, and developability optimization, delivering fully human therapeutic candidates in as little as eight weeks for biopharma and research partners.

Insamo transforms drug discovery for challenging diseases using an automated platform for designing, synthesizing, and testing compounds. This process leverages trillions of proprietary experimental data points across vast chemical space. The company applies scalable machine learning to accelerate and set a new standard for drug design iteration cycles.

Inscopix provides lightweight, head‑mounted miniscope systems (nVue, nVista, nVoke, nVista 2P) for high‑resolution calcium imaging in freely moving animals. The platforms support single‑ and dual‑color fluorescence, optogenetic stimulation, and multi‑site recordings, and are paired with integrated software that automates data acquisition, processing, and analysis. This enables neuroscience labs and biotech teams to link neural circuit activity to behavior and accelerate therapeutic research.

Lassogen is developing Lassotides™, a new class of programmable lasso peptides engineered to target G protein-coupled receptors for the treatment of difficult diseases like cancer and autoimmune disorders. By utilizing a proprietary platform for high-throughput production and optimization, Lassogen aims to enhance therapeutic efficacy and stability while addressing the limitations of traditional antibodies and small molecules.

This company operates a high-throughput in vivo (HTV) discovery engine that combines massively multiplexed in vivo screening with AI-powered design. The engine sculpts pharmacokinetics and biodistribution properties of biologics directly within living systems to solve tissue-specific delivery challenges. Manifold Bio develops targeted medicines, including modular shuttles, optimized in vivo for precise payload delivery across various tissues.

The startup offers an intelligent driver safety system that analyzes driver behavior and road conditions to minimize distracted driving and prevent collisions. This technology enables fleets, auto manufacturers, and insurance companies to enhance safety, streamline claims processing, and improve driver coaching efficiency.

NextSilicon's Maverick-2 Intelligent Compute Accelerator (ICA) utilizes software-defined hardware to dynamically optimize performance for high-performance computing (HPC) and artificial intelligence (AI) workloads. This technology eliminates the need for extensive code rewrites, significantly reducing development time and enabling faster insights across various applications.

NVision Imaging Technologies develops Quantum MRI agents that utilize hyperpolarization to enhance the visibility of metabolic agents in standard MRI scans, enabling rapid assessment of early patient response to cancer treatment at the cellular level. This technology provides critical insights into tumor activity and viability within minutes, allowing for timely adjustments in treatment strategies.